Caricamento...
Psoriasis Induced by Trastuzumab (Herceptin®)
Trastuzumab (Herceptin), a humanized monoclonal antibody, is a cancer drug developed to target the human epidermal receptor (HER) 2, which is overexpressed in some cancer cells. Cutaneous side effects, such as folliculitis, xerosis, and alopecia have not been reported with therapies targeting HER2,...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3662920/ https://ncbi.nlm.nih.gov/pubmed/23717018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2013.25.2.229 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|